| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/18/2010 | WO2010010469A3 Amyloid beta (x - 38.. 43) oligomers, and processes, compositions, and uses thereof |
| 03/18/2010 | WO2010006144A3 Influenza hemagglutinin and neuraminidase variants |
| 03/18/2010 | WO2010005551A3 Heterologous expression of termite cellulases in yeast |
| 03/18/2010 | WO2010004096A3 Culture of cells |
| 03/18/2010 | WO2009154770A3 Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage |
| 03/18/2010 | WO2009153458A3 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 03/18/2010 | WO2009151491A3 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group |
| 03/18/2010 | WO2009137091A3 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders |
| 03/18/2010 | WO2009132209A3 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| 03/18/2010 | WO2009126208A3 Heat resistant plants and plant tissues and methods and materials for making and using same |
| 03/18/2010 | WO2009121024A3 Methods for detecting antibodies |
| 03/18/2010 | WO2009114700A3 Cell model of neurodegenerative disease and methods of use thereof for identifying inhibitors of mitochondrial fusion |
| 03/18/2010 | WO2009108898A3 Production and uses of type 1 ribosome inactivating proteins |
| 03/18/2010 | WO2009074133A3 C-terminal ifapsoriasin fragments as antimicrobial peptides, the production thereof and use thereof |
| 03/18/2010 | WO2009051846A3 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 03/18/2010 | WO2009033715A3 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| 03/18/2010 | WO2005042711A9 Pain-associated gene pnpg1 |
| 03/18/2010 | US20100071091 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 03/18/2010 | US20100069613 Implantable materials and compositions |
| 03/18/2010 | US20100069612 Water-soluble keratin derivative and use thereof |
| 03/18/2010 | US20100069611 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 03/18/2010 | US20100069610 Substrates useful for fret protease assays for botulinum serotype a/e txoins |
| 03/18/2010 | US20100069608 Biomaterial with functionalised surfaces |
| 03/18/2010 | US20100069607 Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products |
| 03/18/2010 | US20100069606 Tubular nanostructure targeted to cell membrane |
| 03/18/2010 | US20100069605 Peptide extended insulins |
| 03/18/2010 | US20100069571 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith |
| 03/18/2010 | US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein |
| 03/18/2010 | US20100069303 Methods of treating bone disease using vascular endothelial growth factor fusion constructs |
| 03/18/2010 | US20100069302 Specific therapy and medicament using integrin ligands for treating cancer |
| 03/18/2010 | US20100069301 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 03/18/2010 | US20100069300 C-Type Lectin Fold as a Scaffold for Massive Sequence Variation |
| 03/18/2010 | US20100069299 Ghrelin analogs |
| 03/18/2010 | US20100069297 Selective Inhibition of TLR4 Signaling |
| 03/18/2010 | US20100069258 Hydrophilic Labels for Biomolecules |
| 03/18/2010 | US20100068818 Algorithms for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer |
| 03/18/2010 | US20100068806 Novel methods and reagents directed to production of cells |
| 03/18/2010 | US20100068803 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof |
| 03/18/2010 | US20100068773 Microbiological production of 3-hydroxyisobutyric acid |
| 03/18/2010 | US20100068763 Mammalian chemokines; receptors; reagents; uses |
| 03/18/2010 | US20100068762 Novel nucleic acid molecules |
| 03/18/2010 | US20100068742 Methods |
| 03/18/2010 | US20100068732 Cloned glucagon-like peptide-2 receptors |
| 03/18/2010 | US20100068692 Antifreeze glycoprotein analogues and uses thereof |
| 03/18/2010 | US20100068690 Tissue preservation and fixation method |
| 03/18/2010 | US20100068517 Enhanced silk protein material having improved mechanical performance and method of forming the same |
| 03/18/2010 | US20100068229 Recombinant antigens of human cytomegalovirus (hcmv) |
| 03/18/2010 | US20100068228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions |
| 03/18/2010 | US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/18/2010 | US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof |
| 03/18/2010 | US20100068217 Epitope-transplant scaffolds and their use |
| 03/18/2010 | US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus |
| 03/18/2010 | US20100068186 High affinity telomerase t cell receptors |
| 03/18/2010 | US20100068175 Methods of using Fc-Cytokine fusion proteins |
| 03/18/2010 | US20100068173 Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects |
| 03/18/2010 | US20100068172 Nematode Control |
| 03/18/2010 | US20100068151 Multimodality molecular imaging with therapeutic conjugates |
| 03/18/2010 | US20100068145 Bispecific fusion protein having therapeutic and diagnostic potential |
| 03/18/2010 | US20100068137 Dock-and-Lock (DNL) Vaccines for Cancer Therapy |
| 03/18/2010 | CA2736632A1 Treating inflammatory conditions |
| 03/18/2010 | CA2736543A1 Non-typhoidal salmonella vaccines |
| 03/18/2010 | CA2736498A1 Compositions and methods for purifying calreticulin |
| 03/18/2010 | CA2735882A1 Production of infectious hepatitis c virus particles in cell culture |
| 03/18/2010 | CA2735476A1 Herbicide tolerant plants |
| 03/18/2010 | CA2679041A1 Recombinant human blood coagulation factor viii protein, composition, use of a recombinant factor viii protein, use of a composition, method of obtaining a recombinant human bloodcoagulation factor viii protein and use thereof |
| 03/17/2010 | EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 03/17/2010 | EP2163640A1 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus |
| 03/17/2010 | EP2163639A1 New tomato ethylene response factors and uses thereof |
| 03/17/2010 | EP2163631A1 Expression cassettes for guard cell-preferential expression in plants |
| 03/17/2010 | EP2163628A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/17/2010 | EP2163627A1 Attenuated liver-stage Plasmodium and vaccin containing the same |
| 03/17/2010 | EP2163626A1 Human FGF-21 gene and gene expression products |
| 03/17/2010 | EP2163625A1 IL-17 and IL-17R homologous polypeptides and therapeutic uses thereof |
| 03/17/2010 | EP2163623A2 Bitter taste receptors |
| 03/17/2010 | EP2163618A2 Fluorescent protein |
| 03/17/2010 | EP2163561A1 NOGO receptor-mediated blockade of axonal growth |
| 03/17/2010 | EP2163560A2 Compositions and methods using RNA interference for control of nematodes in plants |
| 03/17/2010 | EP2163559A1 Generation of artificial binding proteins on the basis of ubiquitin-proteins |
| 03/17/2010 | EP2163558A2 A Counterion Exchange Process for Peptides |
| 03/17/2010 | EP2163260A2 Chimpanzee adenovirus vaccine carriers |
| 03/17/2010 | EP2163255A1 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 03/17/2010 | EP2163254A1 Use of HGF for the manufacture of a medicament for treating fibrotic disorders |
| 03/17/2010 | EP2162529A1 Selective cell therapy for the treatment of renal failure |
| 03/17/2010 | EP2162464A1 Natriuretic fusion proteins |
| 03/17/2010 | EP2162463A1 Vegf-d mutants and their use |
| 03/17/2010 | EP2162462A2 A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 03/17/2010 | EP2162460A2 Vaccines against chlamydia infection |
| 03/17/2010 | EP2162150A1 Vaccine against clostridium perfringens |
| 03/17/2010 | EP2162149A1 Vaccine for the prevention of breast cancer relapse |
| 03/17/2010 | EP1981906B1 Human semen enhancer of viral infection peptides (sevi) and their use |
| 03/17/2010 | EP1773877B1 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions |
| 03/17/2010 | EP1664300B1 A new class of a2delta calcium channel subunits |
| 03/17/2010 | EP1578928B1 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 03/17/2010 | EP1556493B1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 03/17/2010 | EP1506225B2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 03/17/2010 | EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use |
| 03/17/2010 | CN101675079A Binding members for ige molecules |
| 03/17/2010 | CN101675077A cross-species-specific bispecific binders |
| 03/17/2010 | CN101675076A engineered anti-il-23r antibodies |
| 03/17/2010 | CN101675075A Recombinant anti-epidermal growth factor receptor antibody compositions |